The FDA has approved the sBLA of Eisai and Biogen's LEQEMBI for maintenance dosing indicated for the early stages of ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
Letter writers address pardons of Jan. 6 insurrectionists, Portsmouth's inability to fund more affordable housing and Trump's ...
"The best Samsung product for every day use, I love to use it as navigator while playing music on YouTube when driving to the office.." ...
USFDA nod to Leqembi IV maintenance dosing for treatment of early Alzheimer's Disease: Eisai, Biogen
Tokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved the ...
Lava has launched the Yuva Smart, an entry-level smartphone priced at Rs 6,000, offering a 6.75-inch display, 5,000 mAh ...
BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's Supplemental Biologics License Application ...
We've been reviewing routers sent to us from China from time to time including Xiaomi Mi AX6000, GL.iNet GL-MT6000, NanoPi R5S, and others. In late 2024, ...
KDDI-owned Soracom has launched an iSIM solution for global IoT to go with its card-type physical SIMs and chip-style ...
According to a forecast report by Dell’Oro Group, a source for market information about the telecommunications, security, ...
In today's technology-soaked world, it seems unfathomable that sailors aboard advance Navy ships might not have access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback